Post Profile

Biotech hedge fund founder Sam Isaly steps down amid sexual harassment allegations

Former OrbiMed female employees said Isaly made vulgar remarks in the office and exposed women colleagues to pornography, news website STAT reported        
read more


Related Posts

Sam Isaly, Orbimed Now Hold 53.3% of Response Biomedical

Business & Finance / Investing : Insider Monkey

Sam Isaly’s Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp. (ADR)(OTCBB:RPBIF), a rapid on-site diagnostic test provider. The fund now holds 53.3% of...

Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical

Business & Finance / Investing : Insider Monkey

Samuel Isaly‘s hedge fund, Orbimed Advisors, decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) to around 2.89 million shares, from 3.14 million held earlier. Following the decline in holdings, Orbimed’s position amasses 4.7...

Samuel Isaly’s Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share

Business & Finance / Investing : Insider Monkey

Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks. They recently reported selling a piece of their stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT). O...

Orbimed’s Samuel Isaly Steps Down Amid Sexual Harassment Allegations

Business & Finance / Investing : Focus on Funds

Orbimed's Samuel Isaly is stepping down from the $17 billion healthcare investment firm. Orbimed said his departure was part of "years-long succession planning discussions," but it follows allegations of sexual harassment.

The founder of a $14 billion biotech hedge fund is stepping down after sexual harassment allegations

Business & Finance : Business Insider: Clusterstock

Sam Isaly, the 72-year-old founder of the $14 billion biotech hedge fund OrbiMed, is stepping down from his position as managing partner. The firm said Thursday that the move is "pursuant to years-long succession planning discussion...


Copyright © 2016 Regator, LLC